SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tsourapas Panagiotis

(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2019
3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Grp Pres, Lat Am & Asia Pac
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 48,029 D
Common Stock 2,916 I By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 09/10/2021 Common Stock 54,214 61.93 D
Stock Option (Right to Buy) (2) 09/10/2020 Common Stock 44,866 64 D
Stock Option (Right to Buy) (3) 09/13/2024 Common Stock 65,433 68.16 D
Stock Option (Right to Buy) (4) 09/08/2022 Common Stock 60,976 72.99 D
Stock Option (Right to Buy) (5) 09/25/2023 Common Stock 68,698 73 D
Explanation of Responses:
1. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date.
2. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2014 grant date.
3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 13, 2018 grant date.
4. Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.
5. Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kristine Hutchinson, Attorney-in-Fact 08/02/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.